{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:08:38Z","timestamp":1794020918143,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41591-019-0463-x","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T12:19:05Z","timestamp":1559564345000},"page":"962-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Novel correlates of protection against pandemic H1N1 influenza A virus infection"],"prefix":"10.1038","volume":"25","author":[{"given":"Sophia","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-5420","authenticated-orcid":false,"given":"Raffael","family":"Nachbagauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-7650","authenticated-orcid":false,"given":"Daniel","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-8749","authenticated-orcid":false,"given":"Arvind","family":"Rajabhathor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea F.","family":"Guglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nery","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Amanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-1748","authenticated-orcid":false,"given":"Lionel","family":"Gresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7877","authenticated-orcid":false,"given":"Aubree","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"463_CR1","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","volume":"378","author":"H Nair","year":"2011","unstructured":"Nair, H. et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378, 1917\u20131930 (2011).","journal-title":"Lancet"},{"key":"463_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1750-2659.2009.00073.x","volume":"3","author":"WW Thompson","year":"2009","unstructured":"Thompson, W. W. et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir. Viruses 3, 37\u201349 (2009).","journal-title":"Influenza Other Respir. Viruses"},{"key":"463_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","volume":"23","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. & Krammer, F. Universal influenza virus vaccines and therapeutic antibodies. Clin. Microbiol. Infect. 23, 222\u2013228 (2017).","journal-title":"Clin. Microbiol. Infect."},{"key":"463_CR4","doi-asserted-by":"publisher","first-page":"e01463-17","DOI":"10.1128\/mBio.01463-17","volume":"8","author":"H Jacobsen","year":"2017","unstructured":"Jacobsen, H. et al. Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. MBio 8, e01463-17 (2017).","journal-title":"MBio"},{"key":"463_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0026-4","volume":"2","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines 2, 26 (2017).","journal-title":"NPJ Vaccines"},{"key":"463_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coi.2018.04.001","volume":"53","author":"R Nachbagauer","year":"2018","unstructured":"Nachbagauer, R. & Palese, P. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Curr. Opin. Immunol. 53, 51\u201357 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"463_CR7","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70, 767\u2013777 (1972).","journal-title":"J. Hyg. (Lond.)"},{"key":"463_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/infdis\/jir661","volume":"204","author":"SE Ohmit","year":"2011","unstructured":"Ohmit, S. E., Petrie, J. G., Cross, R. T., Johnson, E. & Monto, A. S. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J. Infect. Dis. 204, 1879\u20131885 (2011).","journal-title":"J. Infect. Dis."},{"key":"463_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/oxfordjournals.bmb.a071545","volume":"35","author":"CW Potter","year":"1979","unstructured":"Potter, C. W. & Oxford, J. S. Determinants of immunity to influenza infection in man. Br. Med. Bull. 35, 69\u201375 (1979).","journal-title":"Br. Med. Bull."},{"key":"463_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","volume":"218","author":"EJ Erbelding","year":"2018","unstructured":"Erbelding, E. J. et al. A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J. Infect. Dis. 218, 347\u2013354 (2018).","journal-title":"J. Infect. Dis."},{"key":"463_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1586\/14760584.2013.811193","volume":"12","author":"JE McElhaney","year":"2013","unstructured":"McElhaney, J. E., Coler, R. N. & Baldwin, S. L. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev. Vaccines 12, 759\u2013766 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"463_CR12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","volume":"212","author":"AS Monto","year":"2015","unstructured":"Monto, A. S. et al. Antibody to influenza virus neuraminidase: an independent correlate of protection. J. Infect. Dis. 212, 1191\u20131199 (2015).","journal-title":"J. Infect. Dis."},{"key":"463_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","volume":"19","author":"S Sridhar","year":"2013","unstructured":"Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305\u20131312 (2013).","journal-title":"Nat. Med."},{"key":"463_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-18","volume":"10","author":"L Coudeville","year":"2010","unstructured":"Coudeville, L. et al. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med. Res. Methodol. 10, 18 (2010).","journal-title":"BMC Med. Res. Methodol."},{"key":"463_CR15","doi-asserted-by":"publisher","first-page":"e1003061","DOI":"10.1371\/journal.ppat.1003061","volume":"8","author":"S Cauchemez","year":"2012","unstructured":"Cauchemez, S. et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog. 8, e1003061 (2012).","journal-title":"PLoS Pathog."},{"key":"463_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","volume":"173","author":"Y-Q Chen","year":"2018","unstructured":"Chen, Y.-Q. et al. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173, 417\u2013429.e10 (2018).","journal-title":"Cell"},{"key":"463_CR17","doi-asserted-by":"publisher","first-page":"e02281-16","DOI":"10.1128\/mBio.02281-16","volume":"8","author":"M Rajendran","year":"2017","unstructured":"Rajendran, M. et al. Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic sin. MBio 8, e02281-16 (2017).","journal-title":"MBio"},{"key":"463_CR18","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/infdis\/jiy291","volume":"218","author":"TM Babu","year":"2018","unstructured":"Babu, T. M. et al. Population serologic immunity to human and avian H2N2 viruses in the United States and Hong Kong for pandemic risk assessment. J. Infect. Dis. 218, 1054\u20131060 (2018).","journal-title":"J. Infect. Dis."},{"key":"463_CR19","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","volume":"114","author":"SJ Zost","year":"2017","unstructured":"Zost, S. J. et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc. Natl Acad. Sci. USA 114, 12578\u201312583 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"463_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","volume":"35","author":"RD de Vries","year":"2017","unstructured":"de Vries, R. D. et al. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection. Vaccine 35, 238\u2013247 (2017).","journal-title":"Vaccine"},{"key":"463_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ DiLillo","year":"2014","unstructured":"DiLillo, D. J., Tan, G. S., Palese, P. & Ravetch, J. V. Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo. Nat. Med. 20, 143\u2013151 (2014).","journal-title":"Nat. Med."},{"key":"463_CR22","doi-asserted-by":"publisher","first-page":"e02284-17","DOI":"10.1128\/mBio.02284-17","volume":"9","author":"JK Park","year":"2018","unstructured":"Park, J. K. et al. Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus. MBio 9, e02284-17 (2018).","journal-title":"MBio"},{"key":"463_CR23","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.chom.2014.09.020","volume":"16","author":"A Varble","year":"2014","unstructured":"Varble, A. et al. Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe 16, 691\u2013700 (2014).","journal-title":"Cell Host Microbe"},{"key":"463_CR24","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/infdis\/jit372","volume":"208","author":"S Ng","year":"2013","unstructured":"Ng, S. et al. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J. Infect. Dis. 208, 1320\u20131324 (2013).","journal-title":"J. Infect. Dis."},{"key":"463_CR25","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1128\/JVI.03099-14","volume":"89","author":"W He","year":"2015","unstructured":"He, W. et al. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones. J. Virol. 89, 3610\u20133618 (2015).","journal-title":"J. Virol."},{"key":"463_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis935","volume":"207","author":"RB Couch","year":"2013","unstructured":"Couch, R. B. et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J. Infect. Dis. 207, 974\u2013981 (2013).","journal-title":"J. Infect. Dis."},{"key":"463_CR27","first-page":"e01526","volume":"93","author":"YQ Chen","year":"2018","unstructured":"Chen, Y. Q., Lan, L. Y., Huang, M., Henry, C. & Wilson, P. C. Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance. J. Virol. 93, e01526\u201318 (2018).","journal-title":"J. Virol."},{"key":"463_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1084\/jem.20181624","volume":"216","author":"I Kosik","year":"2019","unstructured":"Kosik, I. et al. Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies. J. Exp. Med. 216, 304\u2013316 (2019).","journal-title":"J. Exp. Med."},{"key":"463_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1128\/JVI.02275-15","volume":"90","author":"TJ Wohlbold","year":"2015","unstructured":"Wohlbold, T. J. et al. Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice. J. Virol. 90, 851\u2013861 (2015).","journal-title":"J. Virol."},{"key":"463_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055\u20131065 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"463_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"463_CR32","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. 22, 1456\u20131464 (2016).","journal-title":"Nat. Med."},{"key":"463_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","volume":"47","author":"CI Paules","year":"2017","unstructured":"Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D. & Fauci, A. S. The pathway to a universal influenza vaccine. Immunity 47, 599\u2013603 (2017).","journal-title":"Immunity"},{"key":"463_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMp1714916","volume":"378","author":"CI Paules","year":"2018","unstructured":"Paules, C. I., Sullivan, S. G., Subbarao, K. & Fauci, A. S. Chasing seasonal influenza: the need for a universal influenza vaccine. N. Engl. J. Med. 378, 7\u20139 (2018).","journal-title":"N. Engl. J. Med."},{"key":"463_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/INF.0000000000001083","volume":"35","author":"S Ng","year":"2016","unstructured":"Ng, S. et al. The timeline of influenza virus shedding in children and adults in a household transmission study of influenza in Managua, Nicaragua. Pediatr. Infect. Dis. J. 35, 583\u2013586 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"463_CR36","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1016\/j.vaccine.2017.09.036","volume":"35","author":"S Ng","year":"2017","unstructured":"Ng, S. et al. Association between haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015. Vaccine 35, 6202\u20136207 (2017).","journal-title":"Vaccine"},{"key":"463_CR37","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","volume":"360","author":"S Massingale","year":"2009","unstructured":"Massingale, S. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360, 2605\u20132615 (2009).","journal-title":"N. Engl. J. Med."},{"key":"463_CR38","unstructured":"WHO Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza (World Health Organization, 2011)."},{"key":"463_CR39","first-page":"e51112","volume":"6","author":"I Margine","year":"2013","unstructured":"Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. 6, e51112 (2013).","journal-title":"J. Vis. Exp."},{"key":"463_CR40","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","volume":"6","author":"TJ Wohlbold","year":"2015","unstructured":"Wohlbold, T. J. et al. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. MBio 6, e02556 (2015).","journal-title":"MBio"},{"key":"463_CR41","unstructured":"Roush, S. W. et al. (eds) M\n                           anual for the Surveillance of Vaccine-preventable Diseases (Centers for Disease Control and Prevention, 2008)."},{"key":"463_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini, Y., Krieger, A. M. & Yekutieli, D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93, 491\u2013507 (2006).","journal-title":"Biometrika"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0463-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0463-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:42:06Z","timestamp":1733942526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-019-0463-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1038\/s41591-019-0463-x","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Icahn School of Medicine at Mount Sinai has filed patent applications regarding influenza virus vaccines. The Krammer laboratory receives funding for universal influenza virus vaccine projects from the Department of Defense, PATH, the Bill and Melinda Gates Foundation and GlaxoSmithKline.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}